Ceftazidime Injectable (iv/im) Generics - Manufacturers & Suppliers
Fortaz, Tazicef(US& EU)
| Product/Composition:- | Ceftazidime Injectable (IV/IM) |
|---|---|
| Strength:- | 1 g, 2 g, 2.5 g, 3 g, 4 g per vial |
| Form:- | Injectable (IV/IM) |
| Reference Brands:- | Fortaz, Tazicef(US& EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Ceftazidime inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against Pseudomonas aeruginosa and other gram-negative bacteria. Benefits include rapid, potent action in severe infections, broad-spectrum activity, and utility in hospital settings for pneumonia, sepsis, and complicated infections.
Ceftazidime injectable is approved in the EU and US for treating severe bacterial infections, including pneumonia, sepsis, and complicated urinary tract infections. In the EU, brands like Fortaz are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval relies on extensive clinical data and manufacturing compliance, with generic formulations available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers and compliance, visit PharmaTradz. We support seamless market access, ensuring adherence to European and American standards for safe, effective antibacterial therapy.